Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 16.9% | 19.3% | 8.3% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 80.8% | 89.7% | 91.5% | 89.4% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | -€0 | -€0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | €0 | €0 |
| % Margin | -1.2% | -2% | 8.9% | 14.7% |
| Other Income/Exp. Net | -€0 | -€0 | -€0 | -€0 |
| Pre-Tax Income | -€0 | -€0 | €0 | €0 |
| Tax Expense | €0 | -€0 | €0 | €0 |
| Net Income | -€0 | -€0 | €0 | €0 |
| % Margin | -3.7% | -4.3% | 6.7% | 8.4% |
| EPS | -0.015 | -0.013 | 0.017 | 0.02 |
| % Growth | -20.3% | -176.2% | -16% | – |
| EPS Diluted | -0.015 | -0.013 | 0.015 | 0.018 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |